The global aortic stents grafts market is projected to witness substantial growth, reaching USD 2.5 billion by 2023 and expanding at a compound annual growth rate (CAGR) of 5% through 2033, when it is expected to reach USD 4.2 billion. This significant growth trajectory is driven by increasing incidences of aortic disorders, particularly among the aging population worldwide.
Aortic disorders, such as aneurysms, are notably prevalent among elderly individuals, contributing to the rising demand for aortic stent grafts. As the global population continues to age, the need for advanced medical interventions like aortic stent grafts is expected to escalate, further bolstering market growth over the next decade.
Get your Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-865
“The projected growth of the global aortic stents grafts market underscores the critical role these devices play in addressing aortic disorders, which are becoming increasingly prevalent among aging populations,” said FMI. “This market expansion reflects advancements in medical technology and the growing adoption of minimally invasive procedures, which are enhancing patient outcomes and driving demand for innovative healthcare solutions.”
Key market players are anticipated to focus on technological innovations and strategic collaborations to capitalize on emerging opportunities in the aortic stents grafts sector. These efforts are aimed at meeting the evolving healthcare needs of aging populations globally and improving accessibility to advanced medical treatments.
Key Takeaways from the Market Study:
- The market for aortic stent grafts in the United Kingdom is expected to reach USD 510 million by 2033.
- The market in China is estimated to reach USD 512 million, expanding at a CAGR of 5% through 2033.
- The aortic stents grafts market in Japan is expected to develop significantly, reaching USD 220 million by 2033.
- The aortic stents grafts market in Germany is expected to experience a 5.1% CAGR through 2033.
“The expanding popularity of testing procedures for early diagnosis of aneurysms, paired with an aging male population, is driving the demand for aortic stent transplants. Since aneurysms, notably AAA, are asymptomatic, early diagnosis may prevent rupture and allow specialists to begin appropriate treatment,” says FMI’s analyst.
Get Customization on This Report: https://www.futuremarketinsights.com/customization-available/rep-gb-865
Competitive Analysis:
Significant participants in the aortic stent grafts industry are investing considerably in advancements in research. Apart from that, they dominate the business through a variety of expansion strategies such as associations, mergers, joint ventures, and creative innovations and credentials.
- Endologix LLC revealed the introduction and first implant of its ALTO® Abdominal Stent Graft in Canada on May 11, 2021, after the latest authorization from Health Canada.
- In March 2022, TERUMO Aortic announced that the PMDA had authorized the RelayPro thoracic stent graft system for the medical care of people in Japan with thoracic aortic aneurysms (TAA). This stent graft system is a contemporary thoracic stent graft with a low profile designed to treat thoracic aneurysms and treat affected people with limited accessibility.
Key Companies Profiled:
- Cook Medical, Inc.
- L. Gore & Associates
- MicroPort Scientific Corporation Inc.
- Medtronic Plc.
- Lombard Medical, Inc.
- Endologix, INC.
- Terumo Corporation Inc.
- Cardinal Health Inc.
- Becton, Dickinson and Company
- Cryolife Inc.
Segmentation Analysis of the Aortic Stents Grafts Market:
Product Type:
- Abdominal Aortic Stents Graft
- Thoracic Aortic Stents Graft
End User:
- Hospitals
- Ambulatory Surgical Centers/Outpatient Surgical Centers
By Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- South Asia & Pacific
- East Asia
- The Middle East & Africa
Get Complete Full Report: https://www.futuremarketinsights.com/checkout/865
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
